U.S. federal trademark · Serial No. 98316319
Research and development in the fields of pharmaceuticals, and nephrology, diseases, disorders, and conditions of the kidneys; Providing medical scientific research information in the fields of nephrology, diseases, disorders, and conditions of the kidneys, and pharmaceuticals.
Pharmaceutical and biological preparations for treating hemodialysis patients; calcimimetics in the nature of pharmaceuticals that mimic the action of calcium on tissues; Pharmaceutical and biological preparations for use in nephrology and endocrinology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions of the kidneys and glands; Pharmaceutical and biological preparations for treating and managing chronic kidney disease (CKD), end stage renal disease (ESRD), secondary hyperparathyroidism (SHPT), and conditions arising from complications of kidney disease and hemodialysis; Therapeutic agents for affecting calcium-sensing receptors on cells and managing calcium levels in the body
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.